The Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has invited applications from eligible entities under the Scheme for Strengthening of Medical Device Industry (SMDI) to promote domestic manufacturing, reduce import dependence, support innovation, and increase the depth of value chains in the medical devices sector.
Applications are invited under two key sub-schemes: the Marginal Investment Scheme for Reducing Import Dependence and the Medical Device Clinical Studies Support Scheme. Under the Marginal Investment Scheme, selected applicants will receive a one-time capital subsidy of up to ₹10 crore on a reimbursement basis for manufacturing key components, raw materials, finished devices, or accessories aimed at reducing import dependence.
The Medical Device Clinical Studies Support Scheme provides financial support of up to ₹5 crore on a reimbursement basis for conducting clinical investigation, clinical performance evaluation, Post Market Follow-up Study, or animal studies to eligible applicants. All proposals under the Scheme must be submitted through the online portal http://smdi.lsssdc.in on or before 23 July 2026 by 6:00 PM. Detailed information regarding eligibility criteria, application procedures, and terms and conditions is available on the Department of Pharmaceuticals website at https://pharma-dept.gov.in/schemes.